You have 9 free searches left this month | for more free features.

HPTH

Showing 1 - 25 of 31

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Hypoparathyroidism Trial in Jerusalem (EBP05, Forteo 20 mg, EBP11)

Recruiting
  • Hypoparathyroidism
  • Jerusalem, Israel
    Clinical Research Center Hadassah Ein Kerem Medical Center
Jul 27, 2023

Osteoporosis Trial in Israel (EBP05, Placebo of EBP05)

Completed
  • Osteoporosis
  • Jerusalem, Israel
  • +3 more
Jun 23, 2021

Hypoparathyroidism, DiGeorge Syndrome Trial run by the NIDCR (PTH 1-34)

Terminated
  • Hypoparathyroidism
  • DiGeorge Syndrome
  • PTH 1-34
  • Bethesda, Maryland
    National Institutes of Health Clinical Center, 9000 Rockville Pi
Aug 19, 2019

Primary Hyperparathyroidism Trial in Boston (eplerenone, amiloride, Placebo)

Completed
  • Primary Hyperparathyroidism
  • Boston, Massachusetts
    Brigham and Women's Hospital
Nov 26, 2021

Knee Osteoarthritis, Chronic Pain Trial in Houston (Soterix 1x1 tDCS mini-CT Stimulator device)

Completed
  • Knee Osteoarthritis
  • Chronic Pain
  • Soterix 1x1 tDCS mini-CT Stimulator device
  • Houston, Texas
    The University of Texas Health Science Center at Houston
Sep 19, 2021

Osteo Arthritis Knee Trial in Houston (Cranial Electrical Stimulation (CES), Sham-CES)

Completed
  • Osteo Arthritis Knee
  • Cranial Electrical Stimulation (CES)
  • Sham-CES
  • Houston, Texas
    The University of Texas Health Science Center at Houston
Oct 21, 2020

Bronchiolitis Obliterans, Chronic Rejection of Lung Transplant, Lung Transplant Rejection Trial in Worldwide (Liposomal

Recruiting
  • Bronchiolitis Obliterans
  • +5 more
  • Liposomal Cyclosporine A
  • Standard of Care
  • Phoenix, Arizona
  • +36 more
Mar 15, 2022

Bronchiolitis Obliterans, Chronic Rejection of Lung Transplant, Lung Transplant Rejection Trial in Worldwide (Liposomal

Recruiting
  • Bronchiolitis Obliterans
  • +5 more
  • Liposomal Cyclosporine A
  • standard of care
  • Phoenix, Arizona
  • +32 more
Mar 15, 2022

d to Developing Multiple Endocrine Neoplasia and Pancreatic

Recruiting
  • Multiple Endocrine Neoplasia
  • +2 more
  • Genome Sequencing
  • Data Review
  • Houston, Texas
    University of Texas MD Anderson Cancer Center
Sep 11, 2019

Adult Idiopathic Generalized Osteoporosis Trial in Omaha, New York (Teriparatide, Saline Placebo)

Completed
  • Adult Idiopathic Generalized Osteoporosis
  • Omaha, Nebraska
  • +1 more
Dec 5, 2019

Osteoporosis Trial in Odense (whole-body vibration, teriparatide)

Completed
  • Osteoporosis
  • Odense, Denmark
    Odense University Hospital
Sep 17, 2020

Hypoparathyroidism Trial in New York (open-label PTH(1-84))

Unknown status
  • Hypoparathyroidism
  • open-label PTH(1-84)
  • New York, New York
    Columbia University Medical Center
Jul 24, 2018

Hypoparathyroidism Trial in New York (PTH1-84 in parent study)

Unknown status
  • Hypoparathyroidism
  • PTH1-84 in parent study
  • New York, New York
    Columbia University Medical Center
Feb 27, 2018

Osteoporosis Trial in West Haverstraw (Teriparatide, )

Completed
  • Osteoporosis
  • West Haverstraw, New York
    Helen Hayes Hospital
Nov 22, 2016

Longitudinal Lactation Bone Density Study

Completed
  • Lactation
  • +2 more
    • Pittsburgh, Pennsylvania
      University of Pittsburgh Medical Center
    Jun 15, 2016

    Osteoporosis Trial in West Haverstraw (Parathyroid Hormone, Alendronate, Teriparatide)

    Completed
    • Osteoporosis
    • Parathyroid Hormone
    • +2 more
    • West Haverstraw, New York
      Helen Hayes Hospital, Clinical Research Center
    Aug 17, 2015

    Osteoporosis Trial in Pittsburgh (Parathyroid hormone related protein (1-36), Parathyroid hormone related protein(1-36),

    Completed
    • Osteoporosis
    • Parathyroid hormone related protein (1-36)
    • +2 more
    • Pittsburgh, Pennsylvania
      UPMC Clinical & Translational Research Center
    Feb 24, 2016

    Osteoporosis, Bone Diseases, Endocrine, Hyperparathyroidism Trial in Pittsburgh, (Parathyroid Hormone (1-34))

    Completed
    • Osteoporosis
    • +2 more
    • Parathyroid Hormone (1-34)
    • Pittsburgh,, Pennsylvania
      University of Pittsburgh Medical Center
    Mar 18, 2016

    Osteoporosis, Humoral Hypercalcemia of Malignancy, Hyperparathyroidism Trial in Pittsburgh (PTHrP (1-36))

    Completed
    • Osteoporosis
    • +2 more
    • PTHrP (1-36)
    • Pittsburgh, Pennsylvania
      University of Pittsburgh Medical Center
    Feb 9, 2016

    Osteoporosis Trial in Boston (Human parathyroid hormone [hPTH-(1-34)], alendronate)

    Completed
    • Osteoporosis
    • Boston, Massachusetts
      Massachusetts General Hospital
    Dec 6, 2013

    Postmenopausal Osteoporosis, Osteoporosis Trial in Boston (synthetic hPTH 1-34)

    Completed
    • Postmenopausal Osteoporosis
    • Osteoporosis
    • synthetic hPTH 1-34
    • Boston, Massachusetts
      Massachusetts General Hospital
    Sep 26, 2013

    Osteoporosis Trial in Pittsburgh (Parathyroid Hormone-related Protein)

    Withdrawn
    • Osteoporosis
    • Parathyroid Hormone-related Protein
    • Pittsburgh, Pennsylvania
      University of Pittsburgh Medical Center
    Sep 3, 2014

    Osteoporosis, Hypercalcemia of Malignancy, Hyperparathyroidism Trial in Pittsburgh (Parathyroid Hormone-related Protein (1-36),

    Withdrawn
    • Osteoporosis
    • +3 more
    • Parathyroid Hormone-related Protein (1-36)
    • +2 more
    • Pittsburgh, Pennsylvania
      University of Pittsburgh Medical Center
    Dec 3, 2014

    Osteoporosis, Osteoporosis, Postmenopausal Trial in Pittsburgh (Parathyroid Hormone-related Protein, Placebo)

    Completed
    • Osteoporosis
    • Osteoporosis, Postmenopausal
    • Parathyroid Hormone-related Protein
    • Placebo
    • Pittsburgh, Pennsylvania
      University of Pittsburgh Medical Center
    Apr 25, 2014

    Healthy, Vitamin D Deficiency Trial in Boston (ergocalciferol, pill)

    Completed
    • Healthy
    • Vitamin D Deficiency
    • ergocalciferol
    • placebo pill
    • Boston, Massachusetts
      Massachusetts General Hospital
    Nov 1, 2013